Advertisement
Screener

NERVGEN PHARMA CORP. (NGEN) Form 6-K: Report of foreign private issuer

NERVGEN PHARMA CORP. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-24: Form 6-K; Period of report 2026-09-24; Description FORM 6-K; Document tm2625558d1_6k.htm.
  • 2026-08-13: Form 6-K; Period of report 2026-08-13; Description FORM 6-K; Document tm2623069d1_6k.htm.
  • 2026-07-02: Form 6-K; Period of report 2026-07-02; Description FORM 6-K; Document tm2619503d3_6k.htm.
  • 2026-06-01: Form 6-K; Period of report 2026-06-01; Description FORM 6-K; Document tm2616544d1_6k.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-246-K2026-09-24FORM 6-Ktm2625558d1_6k.htm
2026-08-136-K2026-08-13FORM 6-Ktm2623069d1_6k.htm
2026-07-026-K2026-07-02FORM 6-Ktm2619503d3_6k.htm
2026-06-016-K2026-06-01FORM 6-Ktm2616544d1_6k.htm
2026-05-266-K2026-05-26FORM 6-Ktm2615621d1_6k.htm
2026-05-226-K2026-05-22FORM 6-Ktm2615291d1_6k.htm
2026-05-186-K2026-05-18FORM 6-Ktm2614980d1_6k.htm
2026-05-156-K2026-05-15FORM 6-Ktm2614733d1_6k.htm
2026-04-276-K2026-04-27FORM 6-Ktm2612795d1_6k.htm
2026-03-136-K2026-03-13FORM 6-Ktm268804d1_6k.htm
2026-02-136-K2026-02-13FORM 6-Ktm266242d1_6k.htm
2026-02-106-K2026-02-10FORM 6-Ktm265749d1_6k.htm
2026-01-086-K2026-01-08FORM 6-Ktm262534d1_6k.htm